Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
about
Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culturePrevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance dataEstimating the potential effects of a vaccine program against an emerging influenza pandemic--United StatesEstimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Serological response of patients with influenza A (H1N1) pdm09-associated pneumonia: an observational study.Assessing the impact of public health interventions on the transmission of pandemic H1N1 influenza a virus aboard a Peruvian navy ship.Inferring influenza infection attack rate from seroprevalence dataIgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United StatesSeroincidence of Influenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 Influenza Pandemic, Bangkok, ThailandSeroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.Influenza immunology evaluation and correlates of protection: a focus on vaccines.A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza PandemicSerologically confirmed household transmission of 2009 pandemic influenza A (H1N1) virus during the first pandemic wave--New York City, April-May 2009.Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.H1N1v at a seroepidemiological glance: is the nightmare over?Transmission of 2009 pandemic influenza A (H1N1) virus among healthcare personnel-Southern California, 2009.The first cases of 2009 pandemic influenza A (H1N1) virus infection in the United States: a serologic investigation demonstrating early transmission.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicDecreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemicMulti-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineInfluenza A(H1N1)pdm09 during air travel.Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians--southwestern United States, May 1-July 21, 2009.Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.Association between antibody titers and protection against influenza virus infection within householdsSerologic assays for influenza surveillance, diagnosis and vaccine evaluation.Influenza infection rates, measurement errors and the interpretation of paired serology.Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCROverview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEComparison of the Roche RealTime ready Influenza A/H1N1 Detection Set with CDC A/H1N1pdm09 RT-PCR on samples from three hospitals in Ho Chi Minh City, Vietnam.Seropositivity for influenza A(H1N1)pdm09 virus among frontline health care personnel.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.Improving influenza virus detection.
P2860
Q28659731-1AE6E2AB-974C-4909-A512-46FE65EF1180Q28741061-8D01F6EB-5920-45B1-A09E-1F274415B584Q30000940-45D3E03B-2130-4136-8B89-3E7077E71CD1Q30204154-E9E878AA-D268-4580-84A8-C3C95C1B59C9Q30223476-8FFF8232-EA7A-43B1-82BF-7AF8137588B5Q30356492-A24A8527-53C8-4136-851C-420962230BEFQ30358784-BF2D824E-413F-44C3-8FB0-A11F69B10D5EQ30361006-4291679A-4863-45D2-99E0-BF388D32BCB7Q30362980-CF379C21-BAEF-47A4-85CA-042AAFB7B8D3Q30372336-38EAF137-CB39-480F-AA3E-E422A955034BQ30373137-AE8D4B7D-9A13-4F25-915F-4E32D8238D63Q30385397-1EA397E9-1E44-469D-8531-DD6CE0D589B0Q30385942-1A3F2007-06A8-4066-A862-FA4F8D59EC16Q30406004-01F5B15B-5B4D-4514-AF13-2F1811B3720CQ30407929-ED222BFE-4DCE-45A1-89F1-7D8E123F5347Q30409115-86575C25-7BD2-4137-9C6A-2A7F517341E7Q30409442-898C6856-87A0-48C8-B5D6-C93A0A7D80C6Q30413353-79C6C92B-C085-4ED3-9F3D-28E7ECA00B5AQ30415228-95A43929-6C19-4EC2-9383-1B59CA0C2F6FQ30415565-58CF40AA-F358-4049-908C-5BF6D52E36B6Q30416214-B4267F31-4D8F-4A8B-9219-1D3860DD3B0DQ30421428-B0D02765-3530-4D21-8922-D72C89104D47Q30423135-45F29EA5-64DF-4386-8FCE-3CD5D2D7E1F4Q30426674-725B6225-84B0-4BAE-AC3F-049A0BDBBACCQ30428646-44BB7C9C-89A1-4A61-9D0F-5B7D484A0F1BQ30429825-FF631056-8548-49D3-A35A-57146AC813DEQ30431244-A8CD1339-E2A3-4293-A5D0-C1E97165AF8FQ33809686-53B90AAB-4748-43F6-8893-AF43C2DAB0D5Q33883224-5408E4CD-823E-4FFC-B2C8-103A6C4C90A4Q34106198-CA960C87-2D7E-4B9C-9714-CB497A969202Q34194336-0FF923B8-BC6E-4E69-B534-CE7F8A0830D3Q34524641-62F47658-AAFB-4416-8FFF-8DFBA204D67AQ34598349-46C6D8C2-DB08-461C-93A7-5C5B33F1510FQ35826733-99E6B0DB-4F16-496D-B7F4-E8ADB6929BD2Q35901999-5FB560CC-B9D4-4815-A2AE-9058735BE922Q36240630-DB79E21B-8898-4FCA-9027-1EB0A04E45E0Q36570806-AE2215F8-AF98-4345-B0A3-50A2C41DB367Q37224897-9CAA0578-C99F-4E10-A375-9AB27FA1DED7Q37311543-C253D004-057E-4128-82DA-EAACD15C6266Q38088381-F3FB7C08-13FA-418D-A141-36F244DF7D50
P2860
Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@ast
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@en
type
label
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@ast
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@en
prefLabel
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@ast
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@en
P2093
P2860
P356
P1476
Sensitivity and specificity of ...... 1N1 virus in U.S. populations.
@en
P2093
Alicia Branch
Byron Tsang
Crystal Holiday
Darbi Aranio
David Wang
Evelene Steward-Clark
Hanan Dababneh
Heather Noland
P2860
P304
P356
10.1128/JCM.00229-11
P407
P577
2011-04-06T00:00:00Z